Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-06

Clinical Trial Update: Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating desloratadine for intermittent allergic rhinitis completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED | Results posted: 2009-03-06